Mallinckrodt Pharmaceuticals

Mallinckrodt Pharmaceuticals is a global specialty pharmaceutical company dedicated to developing, manufacturing, and distributing innovative therapies that improve patients' lives.

Established in 1867 by the Mallinckrodt brothers in St. Louis, Missouri, the company has evolved over more than 150 years into a leading provider of specialty pharmaceuticals. Mallinckrodt's legal domicile is in Dublin, Ireland, with operational headquarters in the United States and executive offices in Staines-upon-Thames, England. The company focuses on addressing unmet medical needs through its diverse portfolio of therapies, particularly in the areas of autoimmune and rare diseases, analgesics, and central nervous system disorders. Mallinckrodt is committed to ethical business practices, sustainability, and delivering value to patients and shareholders alike.

Key Products and Services

Specialty Pharmaceuticals: Mallinckrodt offers a range of specialty pharmaceutical products, including:

Acthar® Gel: An injectable biopharmaceutical used for the treatment of infantile spasms, acute exacerbations of multiple sclerosis, and certain orphan diseases.
Ofirmev®: A proprietary intravenous formulation of acetaminophen used in conjunction with opioid painkillers in the post-surgical setting.
Xartemis XR®: A controlled-release oral combination of acetaminophen and oxycodone for the treatment of acute pain.
Exalgo®: A once-daily, long-acting form of hydromorphone for managing pain.

Specialty Generics and Active Pharmaceutical Ingredients (APIs): The company manufactures generic controlled substances and APIs, such as:

Hydrocodone
Oxycodone
Methadone
Fentanyl
Methylphenidate
Dextroamphetamine
Naloxone
Naltrexone

Medical Imaging: Mallinckrodt provides contrast media and radiopharmaceuticals for medical imaging applications, including:

Optiray® (ioversol injection): An iodide-based contrast medium for CT scans.
Optimark® (gadoversetamide injection): A gadolinium-based contrast agent used in magnetic resonance imaging (MRI) of the brain or liver.

Mallinckrodt is dedicated to advancing sustainability and fostering diversity, equity, and inclusion within its workforce. The company actively engages in community outreach programmes and upholds rigorous standards of business ethics and environmental stewardship. By listening to stakeholders' needs, Mallinckrodt strives to deliver long-term value and make a lasting difference in the lives of patients worldwide.